Page 44 - 南京医科大学学报自然科学版
P. 44
第42卷第7期
·940 · 南 京 医 科 大 学 学 报 2022年7月
产生直接影响 PI3K/Akt 通路降低 HIF1α表达,未来 AKT/HIF⁃1α/HK2 axis of breast cancer cells:combined
将进一步研究 ALCAT1⁃ROS⁃HIF1α轴背后的分子 administration of polydatin and 2⁃deoxy⁃d⁃glucose[J]. J
事件以及与线粒体呼吸和线粒体功能联系,并将 Cell Mol Med,2019,23(5):3711-3723
在更多的癌症模型中去验证 ALCAT1 缺失对肿瘤 [11] WEINBERG F,HAMANAKA R,WHEATON W W,et al.
Mitochondrial metabolism and ROS generation are essen⁃
发生发展的影响。
tial for Kras ⁃ mediated tumorigenicity[J]. PNAS,2010,
综上所述,ALCAT1 的缺失减缓 KRAS 突变导
107(19):8788-8793
致的肺腺癌的发展,在 KRAS 突变的人肺腺癌细胞
[12] PARADIES G,PARADIES V,RUGGIERO F M,et al. Mi⁃
中药理学抑制 ALCAT1 可能通过阻止 ROS 的产生
tochondrial bioenergetics and cardiolipin alterations in
降低 HIF1α表达,从而减少糖酵解代谢产物的生 myocardial ischemia ⁃ reperfusion injury:implications for
成,影响 Akt 磷酸化水平。这为开发新型抗肺癌药 pharmacological cardioprotection[J]. Am J Physiol Heart
物提供了新的干预靶点,也为后续机制研究提供了 Circ Physiol,2018,315(5):H1341-H1352
基础。 [13] SHILOVSKY G A,PUTYATINA T S,ASHAPKIN V V,et
al. Biological diversity and remodeling of cardiolipin in
[参考文献]
oxidative stress and age⁃related pathologies[J]. Biochem
[1] SCHABATH M B,COTE M L. Cancer progress and priori⁃ Biokhimiia,2019,84(12):1469-1483
ties:lung cancer[J]. Cancer Epidemiol Biomark Prev,
[14] GÜRTLER S,WOLKE C,OTTO O,et al. Tafazzin⁃depen⁃
2019,28(10):1563-1579 dent cardiolipin composition in C6 glioma cells correlates
[2] SANAEI M J,RAZI S,POURBAGHERI⁃SIGAROODI A,
with changes in mitochondrial and cellular functions,and
et al. The PI3K/Akt/mTOR pathway in lung cancer;onco⁃ cellular proliferation[J]. Biochim Biophys Acta Mol Cell
genic alterations,therapeutic opportunities,challenges, Biol Lipids,2019,1864(4):452-465
and a glance at the application of nanoparticles[J]. [15] ZHANG J L,YU W D,RYU S W,et al. Cardiolipins are
Transl Oncol,2022,18:101364 biomarkers of mitochondria⁃rich thyroid oncocytic tumors
[3] RECK M,CARBONE D P,GARASSINO M,et al. Target⁃ [J]. Cancer Res,2016,76(22):6588-6597
ing KRAS in non⁃small⁃cell lung cancer:recent progress [16] SCHILD L,DÖRING M,JANSING S,et al. Proliferation
and new approaches[J]. Ann Oncol,2021,32(9):1101- of C6 glioma cells requires the phospholipid remodeling
1110 enzyme tafazzin independent of cardiolipin composition
[4] KAUKO O,O’CONNOR C M,KULESSKIY E,et al. [J]. Biochim Biophys Acta Mol Cell Biol Lipids,2020,
PP2A inhibition is a druggable MEK inhibitor resistance 1865(3):158596
mechanism in KRAS ⁃ mutant lung cancer cells[J]. Sci [17] LI J,ROMESTAING C,HAN X L,et al. Cardiolipin re⁃
Transl Med,2018,10(450):eaaq1093 modeling by ALCAT1 links oxidative stress and mitochon⁃
[5] HU K W,LI K,LV J,et al. Suppression of the SLC7A11/ drial dysfunction to obesity[J]. Cell Metab,2010,12(2):
glutathione axis causes synthetic lethality in KRAS⁃mu⁃ 154-165
tant lung adenocarcinoma[J]. J Clin Investig,2020,130 [18] SONG C J,ZHANG J,QI S S,et al. Cardiolipin remodel⁃
(4):1752-1766 ing by ALCAT1 links mitochondrial dysfunction to Par⁃
[6] WANG X H,JIANG Z H,YANG H M,et al. Hypoxia⁃in⁃ kinson’s diseases[J]. Aging Cell,2019,18(3):e12941
duced FOXO4/LDHA axis modulates gastric cancer cell [19] JIA D D,ZHANG J,NIE J,et al. Cardiolipin remodeling
glycolysis and progression[J]. Clin Transl Med,2021,11 by ALCAT1 links hypoxia to coronary artery disease by
(1):e279 promoting mitochondrial dysfunction[J]. Mol Ther,2021,
[7] MAGAWAY C,KIM E,JACINTO E. Targeting mTOR 29(12):3498-3511
and metabolism in cancer:lessons and innovations[J]. [20] HUANG L S,KOTHA S R,AVASARALA S,et al. Lyso⁃
Cells,2019,8(12):1584 cardiolipin acyltransferase regulates NSCLC cell prolifera⁃
[8] HAM P B,RAJU R. Mitochondrial function in hypoxic tion and migration by modulating mitochondrial dynamics
ischemic injury and influence of aging[J]. Prog Neurobi⁃ [J]. J Biol Chem,2020,295(38):13393-13406
ol,2017,157:92-116 [21] KONSTANTINIDOU G,RAMADORI G,TORTI F,et al.
[9] MORO L. Mitochondrial dysfunction in aging and cancer RHOA⁃FAK is a required signaling axis for the mainte⁃
[J]. J Clin Med,2019,8(11):1983 nance of KRAS⁃driven lung adenocarcinomas[J]. Cancer
[10] ZHANG T,ZHU X,WU H,et al. Targeting the ROS/PI3K/ (下转第972页)